Intrapartum antibiotics for known maternal Group B streptococcal colonization (Q24240155)

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Maternal colonization by group B streptococci and puerperal infection; analysis of intrapartum chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Chlorhexidine vaginal flushings versus systemic ampicillin in the prevention of vertical transmission of neonatal group B streptococcus, at term

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Randomized clinical trial of intrapartum clindamycin cream for reduction of group B streptococcal maternal and neonatal colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Efficacy of intramuscular penicillin in the eradication of group B streptococcal colonization at delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Intrapartum prophylaxis with ceftriaxone decreases rates of bacterial colonization and early-onset infection in newborns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Prevalence of maternal group B streptococcal colonisation in European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Neonatal infections caused by group B streptococci. 3. Incidence in Sweden 1970-71.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Selective Intrapartum Chemoprophylaxis of Neonatal Group B Streptococcal Early-Onset Disease. III. Interruption of Mother-to-Infant Transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Probable early-onset group B streptococcal neonatal sepsis: a serious clinical condition related to intrauterine infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

The significance of group B streptococci in neonatal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Use of intrapartum antibiotics and the incidence of postnatal maternal and neonatal yeast infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Intrapartum antibiotic prophylaxis 1: relative effects of recommended antibiotics on gram-negative pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Neonatal Sepsis and Other Infections Due to Group B Beta-Hemolytic Streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Perinatal mortality in Victoria, Australia: role of group B Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Use of vaginally administered chlorhexidine during labor to improve pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Neonatal group B streptococcal disease: incidence, presentation, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Rapid tests for group B Streptococcus colonization in laboring women: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Impact and risk factors for early-onset group B streptococcal morbidity: analysis of a national, population-based cohort in Sweden 1997-2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Group B Streptococcus: global incidence and vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

A serological differentiation of human and other groups of hemolytic streptococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Group B streptococcal infection in the newborn. Criteria for early detection and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Group B streptococci: the new challenge in neonatal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

The effect of intrapartum penicillin on vaginal group B streptococcus colony counts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Changing etiology and outcome of neonatal septicemia in Riyadh, Saudi Arabia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: a critical review of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Serious bacterial infections in newborn infants in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Population-based risk factors for neonatal group B streptococcal disease: results of a cohort study in metropolitan Atlanta

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Serotype IX, a Proposed New Streptococcus agalactiae Serotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Vaginal chlorhexidine during labour to prevent early-onset neonatal group B streptococcal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Maternal carriage of group B streptococci in developing countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Neonatal septicaemia in Finland 1981-85. Predominance of group B streptococcal infections with very early onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Are we using the optimal strategy for GBS management in pregnancy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Ampicillin Prevents Intrapartum Transmission of Group B Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Intrapartum antibiotics for group B streptococcal colonisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

The Prevention of Early-Onset Neonatal Group B Streptococcal Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

Prevention of neonatal group B streptococcal sepsis by the use of a rapid screening test and selective intrapartum chemoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

Chlorhexidine for prevention of neonatal colonization with group B streptococci. IV. Depressed puerperal carriage following vaginal washing with chlorhexidine during labour

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

Intrapartum chemoprophylaxis of early-onset group B streptococcal disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

A comparison of a new rapid real-time polymerase chain reaction system to traditional culture in determining group B streptococcus colonization

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

[Antibiotics at term. Questions about five severe allergic accidents]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

Perinatal group B streptococcal colonization and infection.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

Maternal colonization with group B Streptococcus and prelabor rupture of membranes at term: the role of induction of labor. TermPROM Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

Transmission of group B streptococci among parturient women and their neonates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

Group B streptococcal carriage and disease: a 6-year prospective study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

Group B streptococcal colonisation and the outcome of pregnancy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

A Comparison of Early-Onset Group B Streptococcal Neonatal Infection and the Respiratory-Distress Syndrome of the Newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

Chemoprophylaxis of early onset Group B streptococcal disease.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

The changing spectrum of group B streptococcal disease in infants: an eleven-year experience in a tertiary care hospital

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

Application of the French guidelines for preventing neonatal group B streptococcal disease in a university hospital

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021

Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD007467.PUB2

7 January 2021